(b)(4).The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.It is unknown at this time if the device will be returned for evaluation.The product remains implanted in the patient, but a revision is planned at a later unspecified date at which time the device may be returned for testing.Multiple mdr reports were filed for this event, please see associated reports: 0001032347-2020-00134, 0001032347-2020-00135, 0001032347-2020-00136, 0001032347-2020-00138, 0001032347-2020-00139, 0001032347-2020-00140.Explantation date is planned for (b)(6) 2020.Concomitant medical products: tmj system left standard mandibular component 50mm / 9 hole, part# 24-6551, lot# 775470b; tmj system right standard mandibular component 55mm / 12 hole, part# 24-6555, lot# 774110b; tmj system right fossa component, small, part# 24-6562, lot# 783360a; tmj system left fossa component, small, part# 24-6563, lot# 787860c; 2.4mm system high torque (ht) cross-drive screw 2.7mm x 8mm, part# 91-2708, lot# unk; 2.4mm system high torque (ht) cross-drive screw 2.7 x 10mm, part# 91-2710, lot# unk; tmj system cross drive fossa screw 2.0mm x 7mm, part# 99-6577, lot# unk.
|
This follow-up report is being submitted to relay additional information.It was reported the patient will undergo removal of bilateral temporomandibular joint implants due to pain, malocclusion, and malpositioning with erosion of the exterior auditory canal.The surgeon does not believe the devices are defective.
|
This follow-up report is being submitted to relay additional information.The complaint is considered confirmed because a revision surgery date was confirmed with the surgeon.No product was returned; therefore, no functional tests or inspections could be performed.The dhr for the fossa component was reviewed and no non-conformances were found.There are no indications of manufacturing defects.This is the only complaint for this part# 24-6563, lot# 787860c.For all non-custom tmj fossa implants in the previous one year (from the notification date) regarding malpositioning, there is a complaint rate of 0.26%, which is no greater than the occurrence listed in the application fmea.For all non-custom tmj fossa implants in the previous one year (from the notification date) regarding malocclusion, there is a complaint rate of 0.48%, which is no greater than the occurrence listed in the application fmea.For all non-custom tmj fossa implants in the previous one year (from the notification date) regarding pain leading to a revision surgery, there is a complaint rate of 0.48%, which is no greater than the occurrence listed in the application fmea.The most likely underlying cause of the complaint is due to the malpositioning of the devices.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|